LOCAL CLINICAL TRIAL OF CANINE CORNEAL ULCERS
Animal Vision Center of Virginia is conducting a year-long clinical trial, from March 2021 to March 2022, to determine if the non-steroidal, anti-inflammatory medication Ketorolac influences the time for corneal ulcer healing. Some studies suggest a high frequency of this medication can delay the rate of ulcer healing. The AVCVA study will assess the effect of low frequency application on healing time, scar tissue formation and patient comfort.
Ketorolac can provide additional ocular pain relief, reduce inflammation and potentially reduce corneal blood vessel formation. This medication will be used in addition to the standard antibiotic therapy pets usually receive for treatment.
CRITERIA FOR THE STUDY:
Dogs diagnosed with corneal ulcers, including superficial ulcers, indolent ulcers, or mid-stromal ulcers without malacia or significant infiltrates included. Exclusions: Deep stromal ulcers and descemetoceles
If the patient meets our criteria, refer within 24 hours and we will offer reduced-cost visits and study medication. This includes 50% off initial visit and study medication, plus 30% off recheck visits and refills of study medication. We have allotted time in our schedule to accommodate same-day referrals.
Upon enrollment, the pet patient will be involved in the study until the ulcer has fully healed—anywhere from a few days to a few months, based on the type of ulcer